Lukas Flatz

16PUBLICATIONS
86CO-AUTHORS
Cancer geneticsGene and molecular therapyImmunogenetics (incl. genetic immunology)Sensory systemsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 14, 2025
Genetic susceptibility in early-onset melanoma: An observational Greek cohort study.

Eftychia Chatziioannou, Katerina Kypreou, Irene Stefanaki

|Oct 13, 2025
Precision medicine in cutaneous melanoma-A comprehensive review.

Markus Reitmajer, Lukas Flatz

|Sep 23, 2025
HLA-A*01:01-B*08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis.

Leonie Müller-Jensen, Lukas Flatz, Omar Hasan Ali

|Sep 18, 2024
Correction: Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.

Nathalie A Lengacher, Julianna J Tomlinson, Ann-Kristin Jochum

|Jul 05, 2024
Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ≥ 75 years: results of a real-world cohort including 456 patients.

A Gawaz, I Wolff, L Nanz

|Jul 03, 2024
Intratumoral administration of daromun in non-melanoma skin cancer: Preliminary results from a phase 2 non-randomized controlled trial.

Lukas Flatz, Nikolaus B Wagner, Natalja Denisjuk

Pageof 3

Frequent Collaborators

5 joint publications

Omar Hasan Ali

4 joint publications

Ann-Kristin Jochum

4 joint publications

Wolfram Jochum

2 joint publications

Julianna J Tomlinson